Go to:
Logótipo
Você está em: Start > Publications > View > Fuel cells operating as an immunosensor for cancer biomarker screening
Publication

Fuel cells operating as an immunosensor for cancer biomarker screening

Title
Fuel cells operating as an immunosensor for cancer biomarker screening
Type
Article in International Scientific Journal
Year
2023
Authors
Ferreira, NS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Carneiro, LPT
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
A.M.F.R. Pinto
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Sales, MGF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
The Journal is awaiting validation by the Administrative Services.
Vol. 14
ISSN: 2590-1370
Indexing
Other information
Authenticus ID: P-00Y-AGA
Abstract (EN): This work presents the first integration of antibodies into one of the electrodes of a passive direct methanol fuel cell (DMFC) to create an autonomous immunosensor for cancer antigen 15¿3 (CA15-3). The anode of the fuel cell was first made of carbon cloth with carbon black, platinum and ruthenium nanoparticles and then modified with anti-CA15-3, while the cathode was made of carbon cloth with carbon black and platinum nanoparticles. This hybrid DMFC (hDMFC), which works as an immunosensor, was fed with dilute methanol to generate a concentration-dependent current. The hDMFC device was calibrated in different media (buffer and serum), by incubating increasing concentrations of CA15-3 standard solutions, ranging from 47 to 750 U/mL. The linear response ranged from 188 to 563 U/mL, and the limit of detection (LoD) was 39.8 U/mL. The selectivity of the biosensor was also evaluated with competing cancer biomarkers, such as carcinoembryonic antigen (CEA), and cancer antigen 125 (CA-125), as well as with other compounds normally present in blood plasma (ascorbic acid, glucose, uric acid and urea), adjusted to the normal range of concentrations in serum. The results obtained indicate good selectivity of the immunosensor in the fuel cell. In general, the immunosensor showed a good response considering its integration into a passive DMFC. It is a good sensor for point-of-care (PoC) diagnosis because it has a good performance in human serum and, most importantly, it pursues electrical autonomy. © 2023 The Author(s)
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Simultaneous detection of human neutrophil elastase and cathepsin G on a single substrate using a fluorometric quantum dots probe and chemometric models (2025)
Article in International Scientific Journal
Mota, AR; Castro, C; Ribeiro, SM; Joao L M Santos; Páscoa, NMJ; Passos, LC; Saraiva, MMFS
Biocompatible cdots dual role: Nanophotosensitizers for hypoxic photodynamic therapy and scavenging nanozyme biosensing (2024)
Article in International Scientific Journal
Susana A. F. Neves; Helena M.R. Gonçalves; Sabela Rodriguez; Rui F.P. Pereira; Rui Vilarinho; Tânia Moniz; Maria Rangel; J. Agostinho Moreira; Paula Martins-Lopes; Filomena Adega; Frank Davis; Séamus P.J. Higson; Marita A. Cardoso
Recommend this page Top
Copyright 1996-2025 © Faculdade de Desporto da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-11-01 at 15:57:24 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book